The Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes.

about

A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan

P2860

Q36759789-1AC25A92-9BE8-4489-A6CE-9C1D4AA88096

P2860

The Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes.

Item

http://www.wikidata.org/entity/Q41469746

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The Comparative Effectiveness ...... ers in Patients With Diabetes.

@en

type

Item

label

The Comparative Effectiveness ...... ers in Patients With Diabetes.

@en

prefLabel

The Comparative Effectiveness ...... ers in Patients With Diabetes.

@en

P1476

The Comparative Effectiveness ...... kers in Patients With Diabetes

@en

P2093

Dean T Eurich

http://www.w3.org/2001/XMLSchema#string

Mu Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Angiotensin receptor blockers and myocardial infarction

Effect of antihypertensive therapy on incident stroke in cohorts with prehypertensive blood pressure levels: a meta-analysis of randomized controlled trials

Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Application of the missing-indicator method in matched case-control studies with incomplete data.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

Angiotensin receptor blockers and risk of myocardial infarction: systematic review.

Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system.

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox.

P304

200-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCH.12647

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Raj Padwal

P577

2015-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26289255

http://www.w3.org/2001/XMLSchema#string

The Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes.

about

P2860

P2860

The Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698